Boehringer Ingelheim Venture Fund

company

Investments

Number of Investments
Number of Lead Investments
7
2
Boehringer Ingelheim Venture Fund has made 7 investments. Their most recent investment was on Nov 29, 2022, when Rgenta Therapeutics, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Nov 29, 2022 Rgenta Therapeutics Series A Biotechnology
Apr 2, 2020 Rgenta Therapeutics Seed Biotechnology Yes
May 14, 2018 Acousia Therapeutics Series B Biotechnology
Dec 11, 2017 Aelin Therapeutics Series A Biotechnology
Dec 14, 2016 Acousia Therapeutics Series A Biotechnology Yes
Apr 10, 2016 STAT-Dx Series C Biotechnology
May 6, 2013 STAT-Dx Series B Biotechnology